Robert Michael - AbbVie Vice President Controller

4AB Stock  EUR 153.42  0.48  0.31%   

President

Mr. Robert A. Michael serves as Chief Financial Officer, Senior Vice President of the Company. Mr. Michael was AbbVies Vice President, Controller, since March 1, 2017 and served as AbbVies Vice President, Treasurer from 2015 to 2016, and as Vice President, Controller, Commercial Operations from 2013 to 2015. He joined Abbott Laboratories in 1993 and held numerous positions in the finance organization. since 2018.
Age 53
Tenure 6 years
Phone847 932 7900
Webhttps://www.abbvie.com

AbbVie Management Efficiency

The company has return on total asset (ROA) of 0.0991 % which means that it generated a profit of $0.0991 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.7239 %, meaning that it generated $0.7239 on every $100 dollars invested by stockholders. AbbVie's management efficiency ratios could be used to measure how well AbbVie manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 59.13 B in total debt. AbbVie Inc has a current ratio of 1.02, suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist AbbVie until it has trouble settling it off, either with new capital or with free cash flow. So, AbbVie's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AbbVie Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AbbVie to invest in growth at high rates of return. When we think about AbbVie's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 9 records

PRESIDENT Age

Shawn VammenSuperior Plus Corp
N/A
Beth SummersSuperior Plus Corp
N/A
Ed BechbergerSuperior Plus Corp
N/A
Rob DorranSuperior Plus Corp
N/A
Michael FarrellSuperior Plus Corp
N/A
Gregory McCamusSuperior Plus Corp
N/A
Jay BachmanSuperior Plus Corp
N/A
Andrew PeytonSuperior Plus Corp
55
Keith WrisleySuperior Plus Corp
N/A
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. ABBVIE INC operates under Drug Manufacturers - Major classification in Germany and is traded on Frankfurt Stock Exchange. It employs 30000 people. AbbVie Inc (4AB) is traded on Frankfurt Exchange in Germany and employs 50,000 people.

Management Performance

AbbVie Inc Leadership Team

Elected by the shareholders, the AbbVie's board of directors comprises two types of representatives: AbbVie inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AbbVie. The board's role is to monitor AbbVie's management team and ensure that shareholders' interests are well served. AbbVie's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AbbVie's outside directors are responsible for providing unbiased perspectives on the board's policies.
Carlos Alban, Executive Vice President - Commercial Operations
Robert Michael, Vice President Controller
Jeffrey Stewart, Senior Vice President U.S. Commercial Operations
Brett Hart, Independent Director
William Chase, Executive Vice President CFO
Roxanne Austin, Independent Director
Perry Siatis, Gen VP
Azita SalekiGerhardt, Senior Vice President - Operations
Scott Reents, VP CFO
Edward Rapp, Independent Director
Richard Gonzalez, Chairman of the Board, CEO
Brian Durkin, Vice President Controller
Thomas Hurwich, Vice President Controller
Frederick Waddell, Independent Director
Robert Alpern, Independent Director
Thomas Hudson, VP Officer
Glenn Tilton, Lead Independent Director
Henry Gosebruch, Executive Vice President Chief Strategy Officer
Elizabeth Shea, VP Relations
Rebecca Roberts, Independent Director
Edward Liddy, Independent Director
William Burnside, Independent Director
Timothy Richmond, Senior Vice President - Human Resources
Nicholas Donoghoe, Senior Vice President - Enterprise Innovation
Laura Schumacher, Executive Vice President - Business Development, External Affairs, General Counsel
Roy Roberts, Independent Director
Michael Severino, Executive Vice President - Research & Development, Chief Scientific Officer
Melody Meyer, Director

AbbVie Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AbbVie a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Thematic Ideas
Explore Investing Ideas  
When determining whether AbbVie Inc is a strong investment it is important to analyze AbbVie's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AbbVie's future performance. For an informed investment choice regarding AbbVie Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for AbbVie Stock analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Global Correlations
Find global opportunities by holding instruments from different markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Please note, there is a significant difference between AbbVie's value and its price as these two are different measures arrived at by different means. Investors typically determine if AbbVie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AbbVie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.